MedTech Innovator yesterday announced the 50 med-tech companies
that have been selected to be a part of their four-month
accelerator program. Amongst those chosen are UK based companies 52
North Health, Oxford Endovascular and Phagenesis, as well as
companies from the US, Canada, France, Germany, Israel, Ireland,
Luxembourg and Singapore.
The accelerator program, which aims to improve the lives of
patients by accelerating the growth of companies that are involved
in the transformation of the healthcare system, provides
individualised mentorship and feedback, funding opportunities and
other support, including IP advice, to early and mid-stage
startups, with the ultimate winner getting a grand prize of
$350,000 and the title of 2022 MedTech Innovator.
